Page last updated: 2024-09-03

lestaurtinib and African Lymphoma

lestaurtinib has been researched along with African Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allchin, RL; Ashworth, A; Barber, R; Beck, D; Blades, M; Elliott, R; Evans, S; Lezina, L; Lord, CJ; Porter, AC; Wagner, SD; Zobel, J	1

Other Studies

1 other study(ies) available for lestaurtinib and African Lymphoma

Article	Year
Synthetic Lethal Screen Demonstrates That a JAK2 Inhibitor Suppresses a BCL6-dependent IL10RA/JAK2/STAT3 Pathway in High Grade B-cell Lymphoma. The Journal of biological chemistry, 2016, 08-05, Volume: 291, Issue:32 Topics: Animals; Burkitt Lymphoma; Carbazoles; Cell Line, Tumor; Furans; Humans; Interleukin-10 Receptor alpha Subunit; Janus Kinase 2; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, SCID; Proto-Oncogene Proteins c-bcl-6; STAT3 Transcription Factor; Xenograft Model Antitumor Assays	2016

Article

Year

Synthetic Lethal Screen Demonstrates That a JAK2 Inhibitor Suppresses a BCL6-dependent IL10RA/JAK2/STAT3 Pathway in High Grade B-cell Lymphoma.

The Journal of biological chemistry, 2016, 08-05, Volume: 291, Issue:32

Topics: Animals; Burkitt Lymphoma; Carbazoles; Cell Line, Tumor; Furans; Humans; Interleukin-10 Receptor alpha Subunit; Janus Kinase 2; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, SCID; Proto-Oncogene Proteins c-bcl-6; STAT3 Transcription Factor; Xenograft Model Antitumor Assays

2016